February 27, 2023
The Pharmaceuticals and Medical Devices Agency (PMDA) is assessing 16 APIs used to treat tuberculosis or other diseases for precautions for paradoxical drug reaction, a move likely to trigger label changes in the near future. According to the agency’s risk...read more